Atopic dermatitis differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 16: | Line 16: | ||
! colspan="9" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations | ! colspan="9" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations | ||
! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings | ! colspan="3" rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Para-clinical findings | ||
| | | colspan="2" rowspan="5" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated factors | ||
|- | |- | ||
! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ! rowspan="4" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography | ||
Line 85: | Line 84: | ||
* Psoriasiform hyperplasia | * Psoriasiform hyperplasia | ||
* Dyskeratosis | * Dyskeratosis | ||
| align="center" style="background:#F5F5F5;" | | | colspan="2" align="center" style="background:#F5F5F5;" | | ||
* | |||
* Family history of atopic dermatitis or other [[atopy]] | * Family history of atopic dermatitis or other [[atopy]] | ||
* Personal history of [[atopy]] ([[asthma]], [[allergic rhinitis]], [[food allergy]]) | * Personal history of [[atopy]] ([[asthma]], [[allergic rhinitis]], [[food allergy]]) | ||
* Active and passive exposure to tobacco | * Active and passive exposure to tobacco | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Contact dermatitis|Allergic contact dermatitis]]<ref name="pmid19447733">{{cite journal |vauthors=Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF |title=Allergic and irritant contact dermatitis |journal=Eur J Dermatol |volume=19 |issue=4 |pages=325–32 |date=2009 |pmid=19447733 |doi=10.1684/ejd.2009.0686 |url=}}</ref> | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Contact dermatitis|Allergic contact dermatitis]]<ref name="pmid19447733">{{cite journal |vauthors=Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF |title=Allergic and irritant contact dermatitis |journal=Eur J Dermatol |volume=19 |issue=4 |pages=325–32 |date=2009 |pmid=19447733 |doi=10.1684/ejd.2009.0686 |url=}}</ref> | ||
Line 115: | Line 112: | ||
| align="center" style="background:#F5F5F5;" |Nl | | align="center" style="background:#F5F5F5;" |Nl | ||
| align="center" style="background:#F5F5F5;" |NA | | align="center" style="background:#F5F5F5;" |NA | ||
| align="center" style="background:#F5F5F5;" | | | colspan="2" align="center" style="background:#F5F5F5;" | | ||
* Contact with allergens in the past 1-2 days | * Contact with allergens in the past 1-2 days | ||
* Positive family history | * Positive family history | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Contact dermatitis|Irritant contact dermatitis]]<ref name="pmid30293200">{{cite journal |vauthors=Bains SN, Nash P, Fonacier L |title=Irritant Contact Dermatitis |journal=Clin Rev Allergy Immunol |volume= |issue= |pages= |date=October 2018 |pmid=30293200 |doi=10.1007/s12016-018-8713-0 |url=}}</ref> | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Contact dermatitis|Irritant contact dermatitis]]<ref name="pmid30293200">{{cite journal |vauthors=Bains SN, Nash P, Fonacier L |title=Irritant Contact Dermatitis |journal=Clin Rev Allergy Immunol |volume= |issue= |pages= |date=October 2018 |pmid=30293200 |doi=10.1007/s12016-018-8713-0 |url=}}</ref> | ||
Line 144: | Line 139: | ||
* Intraepidermal vesicles or bullae | * Intraepidermal vesicles or bullae | ||
* Necrosis of keratinocytes | * Necrosis of keratinocytes | ||
| align="center" style="background:#F5F5F5;" | | | colspan="2" align="center" style="background:#F5F5F5;" | | ||
* Cumulative exposure to irritants | * Cumulative exposure to irritants | ||
* Negative hypersensitivity tests | * Negative hypersensitivity tests | ||
|- | |- | ||
Line 176: | Line 170: | ||
* Psoriasiform hyperplasia | * Psoriasiform hyperplasia | ||
* Neutrophils at the margins | * Neutrophils at the margins | ||
| align="center" style="background:#F5F5F5;" | | | colspan="2" align="center" style="background:#F5F5F5;" | | ||
* Stress | * Stress | ||
* Cold, dry weather can cause flare ups | * Cold, dry weather can cause flare ups | ||
* Super infection with bacteria and candida | * Super infection with bacteria and candida | ||
* Generalized seborrheic erythroderma in immunodeficient patients | * Generalized seborrheic erythroderma in immunodeficient patients | ||
Line 207: | Line 200: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | colspan="2" align="center" style="background:#F5F5F5;" | | ||
* Smoking | * Smoking | ||
* Skin trauma | * Skin trauma | ||
Line 215: | Line 208: | ||
* Vitamin D deficiency | * Vitamin D deficiency | ||
* Drugs | * Drugs | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Lichen simplex chronicus|Lichen simplex]] <ref name="pmid28785363">{{cite journal |vauthors=Voicu C, Tebeica T, Zanardelli M, Mangarov H, Lotti T, Wollina U, Lotti J, França K, Batashki A, Tchernev G |title=Lichen Simplex Chronicus as an Essential Part of the Dermatologic Masquerade |journal=Open Access Maced J Med Sci |volume=5 |issue=4 |pages=556–557 |date=July 2017 |pmid=28785363 |pmc=5535688 |doi=10.3889/oamjms.2017.133 |url=}}</ref>[[Lichen simplex chronicus|chronicus]] | ! align="center" style="background:#DCDCDC;" |[[Lichen simplex chronicus|Lichen simplex]] <ref name="pmid28785363">{{cite journal |vauthors=Voicu C, Tebeica T, Zanardelli M, Mangarov H, Lotti T, Wollina U, Lotti J, França K, Batashki A, Tchernev G |title=Lichen Simplex Chronicus as an Essential Part of the Dermatologic Masquerade |journal=Open Access Maced J Med Sci |volume=5 |issue=4 |pages=556–557 |date=July 2017 |pmid=28785363 |pmc=5535688 |doi=10.3889/oamjms.2017.133 |url=}}</ref>[[Lichen simplex chronicus|chronicus]] | ||
Line 240: | Line 232: | ||
* Thick granular zone | * Thick granular zone | ||
* Acanthosis | * Acanthosis | ||
| align="center" style="background:#F5F5F5;" | | | colspan="2" align="center" style="background:#F5F5F5;" | | ||
* Emotional stress | * Emotional stress | ||
* Sleep disturbances | * Sleep disturbances | ||
Line 246: | Line 238: | ||
* Sweating | * Sweating | ||
* Excessive dryness | * Excessive dryness | ||
* Sexual dysfunction | |||
* Sexual dysfunction | |||
* Sleep disturbances | * Sleep disturbances | ||
* Depression | * Depression | ||
Line 281: | Line 272: | ||
* Thick stratum corneum | * Thick stratum corneum | ||
* Basket-weave pattern of stratum corneum | * Basket-weave pattern of stratum corneum | ||
| align="center" style="background:#F5F5F5;" | | | colspan="2" align="center" style="background:#F5F5F5;" | | ||
* Dry and cold weather | * Dry and cold weather | ||
* Increased risk of atopic diseases including asthma, alllergic rhinitis and atopic dermatitis | * Increased risk of atopic diseases including asthma, alllergic rhinitis and atopic dermatitis | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Nummular dermatitis|Nummular dermatitis (discoid eczema)]] | ! align="center" style="background:#DCDCDC;" |[[Nummular dermatitis|Nummular dermatitis (discoid eczema)]] | ||
Line 309: | Line 298: | ||
* Spongiosis | * Spongiosis | ||
* Perivascular lymphocytic infiltrates, with eosinophils and occasional neutrophils | * Perivascular lymphocytic infiltrates, with eosinophils and occasional neutrophils | ||
| align="center" style="background:#F5F5F5;" | | | colspan="2" align="center" style="background:#F5F5F5;" | | ||
* Temperature changes (particularly winter) | * Risk factors: | ||
* Emotional stress | ** Temperature changes (particularly winter) | ||
* Dry skin | ** Emotional stress | ||
* Environmental irritants | ** Dry skin | ||
* Recent surgery | ** Environmental irritants | ||
* Medications like topical antibiotic creams and isotretinoin | ** Recent surgery | ||
** Medications like topical antibiotic creams and isotretinoin | |||
* Superinfection with ''staphylococcus aureus'' | * Superinfection with ''staphylococcus aureus'' | ||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Netherton's syndrome]]<ref name="pmid10835624">{{cite journal |vauthors=Chavanas S, Bodemer C, Rochat A, Hamel-Teillac D, Ali M, Irvine AD, Bonafé JL, Wilkinson J, Taïeb A, Barrandon Y, Harper JI, de Prost Y, Hovnanian A |title=Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome |journal=Nat. Genet. |volume=25 |issue=2 |pages=141–2 |date=June 2000 |pmid=10835624 |doi=10.1038/75977 |url=}}</ref> | ! align="center" style="background:#DCDCDC;" |[[Netherton's syndrome]]<ref name="pmid10835624">{{cite journal |vauthors=Chavanas S, Bodemer C, Rochat A, Hamel-Teillac D, Ali M, Irvine AD, Bonafé JL, Wilkinson J, Taïeb A, Barrandon Y, Harper JI, de Prost Y, Hovnanian A |title=Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome |journal=Nat. Genet. |volume=25 |issue=2 |pages=141–2 |date=June 2000 |pmid=10835624 |doi=10.1038/75977 |url=}}</ref> | ||
Line 359: | Line 347: | ||
* Dermal inflammatory infiltrate including neutrophils and eosinophils | * Dermal inflammatory infiltrate including neutrophils and eosinophils | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Atopic diseases including | * Atopic diseases including asthma, atopic dermatitis and allergic rhinitis | ||
* Systemic and skin superinfections | |||
* Failure to thrive | |||
* Electrolyte imbalances, including hypernatremic dehydration | |||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
** Systemic and skin superinfections | ** Systemic and skin superinfections | ||
Line 383: | Line 374: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ||
! | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated factors | ||
|- | |- | ||
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Infection | ! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Infection | ||
Line 427: | Line 417: | ||
* Keratinocytes containing eosinophilic inclusion bodies (Henderson-Paterson bodies) | * Keratinocytes containing eosinophilic inclusion bodies (Henderson-Paterson bodies) | ||
* H&E stain - inwards indentation of the epidermis | * H&E stain - inwards indentation of the epidermis | ||
| align="center" style="background:#F5F5F5;" | | | colspan="2" align="center" style="background:#F5F5F5;" | | ||
* Often asymptomatic | * Often asymptomatic | ||
* Tender or pruritic skin lesions | * Tender or pruritic skin lesions | ||
* Self resolve within 2 months | * Self resolve within 2 months | ||
* Immunocompetent patients present with extensive and severe infections | * Immunocompetent patients present with extensive and severe infections | ||
* Molluscum contagiosum lesions on the eyelid may lead to follicular or papillary conjunctivitis | |||
lesions on the eyelid may lead to follicular or papillary conjunctivitis | |||
|- | |- | ||
! align="center" style="background:#DCDCDC;" |[[Scabies]] | ! align="center" style="background:#DCDCDC;" |[[Scabies]] | ||
Line 452: | Line 440: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
| align="center" style="background:#F5F5F5;" | | | colspan="2" align="center" style="background:#F5F5F5;" | | ||
* Positive family history | * Positive family history | ||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immunologic disorders | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immunologic disorders | ||
Line 481: | Line 468: | ||
* Sub-epidermal blisters containing neutrophils, eosinophils, and fibrin | * Sub-epidermal blisters containing neutrophils, eosinophils, and fibrin | ||
* Sub-epidermal vacuolization | * Sub-epidermal vacuolization | ||
| align="center" style="background:#F5F5F5;" | | | colspan="2" align="center" style="background:#F5F5F5;" | | ||
* Intermittent pruritic papules and vesicles | * Intermittent pruritic papules and vesicles | ||
* Associated small intestine celiac disease with villous atrophy and crypt hyperplasia | * Associated small intestine celiac disease with villous atrophy and crypt hyperplasia | ||
* Abdominal bloating, pain, diarrhea, or constipation | |||
* Abdominal bloating, pain, diarrhea, or constipation | |||
|- | |- | ||
! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immune deficiency | ! rowspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Immune deficiency | ||
Line 520: | Line 506: | ||
* Epidermal psoriasiform [[hyperplasia]] | * Epidermal psoriasiform [[hyperplasia]] | ||
* Marked intercellular [[edema]] with spongiotic vesiculation | * Marked intercellular [[edema]] with spongiotic vesiculation | ||
| align="center" style="background:#F5F5F5;" | | | colspan="2" align="center" style="background:#F5F5F5;" | | ||
* | * ↑ serum immunoglobulin A (IgA) levels | ||
* ↑ serum immunoglobulin E (IgE) levels | |||
* Thrombocytopenia | |||
* Bleeding: severe thrombocytopenia, | |||
* Eczema - similar to atopic dermatitis | * Eczema - similar to atopic dermatitis | ||
* Recurrent sino-pulmonary infections | * Recurrent sino-pulmonary infections | ||
Line 527: | Line 516: | ||
* Autoimmune diseases | * Autoimmune diseases | ||
* Malignancies | * Malignancies | ||
|- | |- | ||
! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hyper-IgE syndrome]]<ref name="pmid24058807">{{cite journal |vauthors=Mogensen TH |title=STAT3 and the Hyper-IgE syndrome: Clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertainties |journal=JAKSTAT |volume=2 |issue=2 |pages=e23435 |date=April 2013 |pmid=24058807 |pmc=3710320 |doi=10.4161/jkst.23435 |url=}}</ref> | ! style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Hyper-IgE syndrome]]<ref name="pmid24058807">{{cite journal |vauthors=Mogensen TH |title=STAT3 and the Hyper-IgE syndrome: Clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertainties |journal=JAKSTAT |volume=2 |issue=2 |pages=e23435 |date=April 2013 |pmid=24058807 |pmc=3710320 |doi=10.4161/jkst.23435 |url=}}</ref> | ||
Line 564: | Line 549: | ||
| align="center" style="background:#F5F5F5;" | | | align="center" style="background:#F5F5F5;" | | ||
* Eosinophil-rich infiltration around the hair follicles | * Eosinophil-rich infiltration around the hair follicles | ||
| align="center" style="background:#F5F5F5;" | | | colspan="2" align="center" style="background:#F5F5F5;" | | ||
* Cold abscesses | * Cold abscesses | ||
Line 573: | Line 558: | ||
* Peripheral T-cell lymphoma | * Peripheral T-cell lymphoma | ||
* Coronary artery aneurysms | * Coronary artery aneurysms | ||
|- | |- | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Malignancy | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Malignancy | ||
Line 608: | Line 591: | ||
* Epidermis is spared or has minimal spongiosis | * Epidermis is spared or has minimal spongiosis | ||
* Band-like dermal infiltrate of lymphocytes and and histiocytes | * Band-like dermal infiltrate of lymphocytes and and histiocytes | ||
| align="center" style="background:#F5F5F5;" | | | colspan="2" align="center" style="background:#F5F5F5;" | | ||
* Increased risk of : | * Increased risk of : | ||
** Severe viral and bacterial infections | ** Severe viral and bacterial infections | ||
** Secondary malignancies, especially lymphomas | ** Secondary malignancies, especially lymphomas | ||
* Staging of Mycosis fungoides is based upon: | * Staging of Mycosis fungoides is based upon: | ||
** Patches | ** Patches | ||
Line 639: | Line 621: | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |ESR/CRP | ||
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Histopathology | ||
! | ! colspan="2" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated factors | ||
|} | |} | ||
Revision as of 15:18, 25 October 2018
Atopic dermatitis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Atopic dermatitis differential diagnosis On the Web |
American Roentgen Ray Society Images of Atopic dermatitis differential diagnosis |
Risk calculators and risk factors forAtopic dermatitis differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Differentiating Atopic Dermatitis from other Diseases
Category | Diseases | Etiology | Inherited | Acquired | Clinical manifestations | Para-clinical findings | Associated factors | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Demography | Symptoms | Physical examination | ||||||||||||||||
Lab Findings | Histopathology | |||||||||||||||||
Appearance | Itching | Fever | Tenderness | Other | CBC | Serum IgE | ||||||||||||
Single/
Multiple |
Rash | Involved areas | Pustule | WBC | ||||||||||||||
Skin disorders | Atopic dermatitis |
|
+ | + |
|
Multiple |
|
– | + | – | – |
|
Nl to ↑
(Eosinophilia) |
↑ |
|
| ||
Allergic contact dermatitis[1] |
|
– | + | Any | May be multiple after 1-2 days of exposure | Erythematous well-demarcated papules | Surrounding the area in contact with the offending agent | – | + | – | + |
|
Nl to ↑
(Eosinophilia) |
Nl | NA |
| ||
Irritant contact dermatitis[2] |
|
– | + | Any, more occupational exposure | Usually single immediately after the exposure | Well-demarcated red patch with a glazed surface | Any area in contact with the irritant | – | + | – | + |
|
Nl | Nl |
|
| ||
Seborrheic dermatitis |
|
– | + | Any, onset during the infancy and peak during 3rd-4th decades | Multiple |
|
Scalp, face, trunk, postauricular, diaper area and axilla | + | + | – | – |
|
Nl | Nl |
|
| ||
Psoriasis |
|
+ | + | Any, 2 peaks of onset 30-39 years and 50-59 years | Multiple | Well-circumscribed, pink papules and symmetrically distributed cutaneous plaques with silvery scales |
|
+ | + | _ | + |
|
| |||||
Lichen simplex [3]chronicus |
|
– | + | Any, peak at 30-50 years of age | Multiple | Lichenified and erythematous, pruritic exudative plaque, and excoriations | Scalp, head, neck, hands, arms, and genitals areas | – | + | – | – |
|
Nl | Nl |
|
| ||
Ichthyosis vulgaris[4] |
|
+ | + | Usually in infancy | Multiple |
|
|
– | – | – | – |
|
Nl | Nl |
|
| ||
Nummular dermatitis (discoid eczema) | Unknown | – | + | Any, two peaks, 6th-7th decade of life in males and 2nd-3rd decade of life in females | Multiple | Nl |
|
– | + | – | – |
|
Nl | Nl |
|
| ||
Netherton's syndrome[5] | Autosomal recessive mutations in the serine protease inhibitor of Kazal type 5 gene (SPINK5), encoding LEKTI, a serine protease inhibitor | + | – | Affects neonates | Multiple |
|
|
+ | + | – | – |
|
Nl to ↑
(Eosinophilia) |
↑ |
|
|
| |
Diseases | Etiology | Inherited | Acquired | Demography | Single/
Multiple |
Rash | Involved areas | Pustule | Itching | Fever | Tenderness | Other | WBC | ESR/CRP | Histopathology | Associated factors | ||
Infection | Dermatophytes | |||||||||||||||||
Molluscum contagiosum | Molluscum contagiosum virus inoculation through direct skin contact | – | + | Any, peak among children >5 years of age and young adults | Multiple |
|
|
– | + | – | – | If molluscum contagiosum is acquired as sexually transmitted disease, it involves, groin and genital region. | Nl | Nl |
|
| ||
Scabies | Multiple | Erythematous papular lesions | Flexor wrists, finger webs and genitalia | +++ |
| |||||||||||||
Immunologic disorders | Dermatitis herpetiformis[6] | Autoimmune disorder as a result of gluten sensitivity leading to the formation of IgA antibodies | – | + | Any, mean age of disease onset is 2nd-4th decade | Multiple |
|
|
– | + | – | – |
|
Nl | Nl |
|
| |
Immune deficiency | Wiskott-Aldrich syndrome[7] |
|
+ | – | Seen almost exclusively in males in infancy | Multiple |
|
Rash can involve lesions located at the same areas of classical atopic dermatitis:
extensor surfaces of extremities and cheeks or scalp |
– | + | – | – | Infants can present with petechiae, prolonged bleeding from umbilicus or circumcision, purpura, hematemesis, melena, epistaxis, hematuria or unusal bruising | Nl to ↑
(Eosinophilia) |
↑ |
|
| |
Hyper-IgE syndrome[8] |
|
+ | – | Rare, begin in infancy | Multiple |
|
|
+ | + | – | – |
|
Nl to ↑
(Eosinophilia) |
↑ |
|
| ||
Malignancy | Mycosis fungoides | Clonal expansion of CD4+ memory T cells (CD45RO+) | – | + | Mean age is 55- 60 years | Multiple |
|
|
– | + | – | – |
|
Nl | Nl |
|
| |
Category | Diseases | Etiology | Inherited | Acquired | Demography | Single/
Multiple |
Rash | Involved areas | Pustule | Itching | Fever | Tenderness | Other | WBC | ESR/CRP | Histopathology | Associated factors |
References
- ↑ Nosbaum A, Vocanson M, Rozieres A, Hennino A, Nicolas JF (2009). "Allergic and irritant contact dermatitis". Eur J Dermatol. 19 (4): 325–32. doi:10.1684/ejd.2009.0686. PMID 19447733.
- ↑ Bains SN, Nash P, Fonacier L (October 2018). "Irritant Contact Dermatitis". Clin Rev Allergy Immunol. doi:10.1007/s12016-018-8713-0. PMID 30293200.
- ↑ Voicu C, Tebeica T, Zanardelli M, Mangarov H, Lotti T, Wollina U, Lotti J, França K, Batashki A, Tchernev G (July 2017). "Lichen Simplex Chronicus as an Essential Part of the Dermatologic Masquerade". Open Access Maced J Med Sci. 5 (4): 556–557. doi:10.3889/oamjms.2017.133. PMC 5535688. PMID 28785363.
- ↑ Thyssen JP, Godoy-Gijon E, Elias PM (June 2013). "Ichthyosis vulgaris: the filaggrin mutation disease". Br. J. Dermatol. 168 (6): 1155–66. doi:10.1111/bjd.12219. PMID 23301728.
- ↑ Chavanas S, Bodemer C, Rochat A, Hamel-Teillac D, Ali M, Irvine AD, Bonafé JL, Wilkinson J, Taïeb A, Barrandon Y, Harper JI, de Prost Y, Hovnanian A (June 2000). "Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome". Nat. Genet. 25 (2): 141–2. doi:10.1038/75977. PMID 10835624.
- ↑ Kárpáti S (2012). "Dermatitis herpetiformis". Clin. Dermatol. 30 (1): 56–9. doi:10.1016/j.clindermatol.2011.03.010. PMID 22137227.
- ↑ Buchbinder D, Nugent DJ, Fillipovich AH (2014). "Wiskott-Aldrich syndrome: diagnosis, current management, and emerging treatments". Appl Clin Genet. 7: 55–66. doi:10.2147/TACG.S58444. PMC 4012343. PMID 24817816.
- ↑ Mogensen TH (April 2013). "STAT3 and the Hyper-IgE syndrome: Clinical presentation, genetic origin, pathogenesis, novel findings and remaining uncertainties". JAKSTAT. 2 (2): e23435. doi:10.4161/jkst.23435. PMC 3710320. PMID 24058807.